Results 201 to 210 of about 1,571,635 (343)
This study leverages NHANES data to analyze 49 routine indicators, identifying the top 10 diagnostic markers for five major diseases and introducing GLM7, a novel indicator. Restricted cubic spline analyses, forest plot evaluations, and XGBoost modeling demonstrate conventional indicators' efficacy and GLM7's value for disease diagnosis/prediction ...
Zhihua Wang +8 more
wiley +1 more source
Measures of effect: Relative risks, odds ratios, risk difference, and ‘number needed to treat’ [PDF]
Giovanni Tripepi +4 more
openalex +1 more source
Elevated levels of the plasticizer DEHP associate with earlier breast cancer diagnosis. DEHP enhances glutamine‐powered energy production via the transporter SLC6A14 and pushes mitochondria toward fusion, driving tumor initiation by boosting cancer stemness. Blocking SLC6A14 lowers stemness, slows tumors, and improves chemotherapy response.
Dai‐Wei Hu +15 more
wiley +1 more source
Efficient odds ratio estimation under two-phase sampling using error-prone data from a multi-national HIV research cohort. [PDF]
Lotspeich SC +4 more
europepmc +1 more source
Dichotomous transformations for statistical inference about odds ratios [PDF]
Xiangning Huang, Baibing Li
openalex +1 more source
A minimal computational model of cellular aggregate formation in neurodegenerative disease, encompassing two competing processes: cell‐autonomous and cell‐to‐cell triggers of aggregation, is presented. Despite its simplicity, the model can reproduce the aggregate patterns observed in post‐mortem brain images from the primary tauopathy Progressive ...
Shih‐Huan Huang +8 more
wiley +1 more source
Testing the homogeneity of odds ratio across strata for combined bilateral and unilateral data. [PDF]
Hua S, Ma C.
europepmc +1 more source

